Network·Hedge Fund
📍 SEATTLE, WA
SEC CRD #802-110747
Flying Fish Ventures | Seattle Greater PNW Venture Capital Firm About Team Companies Resources Link Four Contact us Investing in the transformative power of Artificial Intelligence and Machine Learning. About us Pre-Seed and Seed Investors Partnering with Visionary Founders We believe Artificial Intelligence will disrupt every industry. About Flying Fish Ventures Companies AI-native threat model intelligence platform that turns overwhelming vulnerability data into clear, attacker-driven priorities to free up your team to focus on real risk. Applied Intelligence AI-native threat model intelligence platform that turns overwhelming vulnerability data into clear, attacker-driven priorities to free up your team to focus on real risk. January 26, 2026 • Streamlining Reinforcement Learning for building superhuman intelligence. Foundational AI Infrastructure Streamlining Reinforcement Learning for building superhuman intelligence. January 7, 2026 • A new paradigm for understanding consumer preference. Applied Intelligence A new paradigm for understanding consumer preference. November 1, 2025 • Accipiter Biosciences designs and develops de novo protein therapies — unbound by natural limitations — to address the world’s most complex diseases. Partnered with Pfizer and Kite Pharma, a Gilead Company. Hard Sciences Accipiter Biosciences designs and develops de novo protein therapies — unbound by natural limitations — to address the world’s most complex diseases. Partnered with Pfizer and
GEOFF HARRIS
GENERAL PARTNER
📞 (206) 618-4464
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Check Size
$5M–$5M
Location
SEATTLE, WA
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.